Detalles de la búsqueda
1.
Lower Serologic Response to COVID-19 mRNA Vaccine in Patients With Inflammatory Bowel Diseases Treated With Anti-TNFα.
Gastroenterology
; 162(2): 454-467, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34717923
2.
Early Indolent Course of Crohn's Disease in Newly Diagnosed Patients Is Not Rare and Possibly Predictable.
Clin Gastroenterol Hepatol
; 19(8): 1564-1572.e5, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32629126
3.
Pregnancy Outcomes in a Cohort of Patients with Inflammatory Bowel Disease: Data from a Multidisciplinary Clinic in a Tertiary Center.
J Clin Med
; 12(12)2023 Jun 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37373814
4.
Serologic Response and Safety after a Third Dose of the COVID-19 BNT162b2 Vaccine in Patients with Inflammatory Bowel Diseases.
Vaccines (Basel)
; 11(7)2023 Jul 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37515078
5.
Short-term effectiveness and safety of tofacitinib in ulcerative colitis - real world data from tertiary medical centers in Israel.
Dig Liver Dis
; 54(2): 192-197, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34887214
6.
Anti-TNFα Treatment Impairs Long-Term Immune Responses to COVID-19 mRNA Vaccine in Patients with Inflammatory Bowel Diseases.
Vaccines (Basel)
; 10(8)2022 Jul 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-35893835
7.
Clinical approach to skin eruptions induced by anti-TNF agents among patients with inflammatory bowel diseases: insights from a multidisciplinary IBD-DERMA clinic.
Therap Adv Gastroenterol
; 14: 17562848211053112, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34777576
Resultados
1 -
7
de 7
1
Próxima >
>>